Compare ARK Genomic Revolution ETF (ARKG) vs Paychex, Inc. (PAYX) Price & Performance
Price performance (Past 24H)
Key statistics
Key statistics
ARK Genomic Revolution ETF vs Paychex, Inc. — how do they compare? ARK Genomic Revolution ETF trades at $44.46, while Paychex, Inc. trades at $121.17 (market cap $42.81B). The key difference: Paychex, Inc. pays a 3.95% dividend while ARK Genomic Revolution ETF pays none, and ARK Genomic Revolution ETF is trading nearer its 52-week high, Paychex, Inc. nearer its low. Which is the better fit depends on your goals.
| ARKG | PAYX | |
|---|---|---|
Sector | Sector/Thematic | Industrials |
52-Week High | $44.69 | $140.81 |
52-Week Low | $24.02 | $85.57 |
Market Cap | — | $42.81B |
Enterprise Value | — | $46.30B |
Dividend Yield | — | 3.95% |
Aura AI Summary
Signals from Pluang's Aura AI — not financial advice
Aura AI Summary
Signals from Pluang's Aura AI — not financial advice
ARKG trades at $44.69 with a 0.86% daily gain, showing bullish momentum with strong moving average signals but overbought oscillators. The ETF focuses on genomic revolution companies with 59% concentration in top 10 holdings and long-term EPS growth of 10.7%. Recent news highlights biotech sector strength and ARKG's recovery from July correction.
Outlook remains positive given biotech sector tailwinds including FDA friendliness and AI-driven drug discovery, though high RSI readings suggest near-term caution. Key risks include sector volatility and concentrated portfolio exposure.
Paychex (PAYX) trades at $120.34, down 0.69% on the day, with a bullish technical signal from moving averages but overbought RSI readings. The company shows strong profitability with a 27.03% net income margin and consistent earnings beats, though valuation ratios like a P/E of 24.81 are elevated. Recent news highlights steady small business employment data and product expansion, supporting its core HR services business.
The outlook is mixed: solid fundamentals and dividend payments offer stability, but high valuation and analyst caution (63.33% hold rating) suggest limited near-term upside. Risks include economic sensitivity and debt levels, yet long-term growth in HR outsourcing remains a tailwind for patient investors.
Returns comparison
Trailing returns across standard periods
Returns comparison
Trailing returns across standard periods
About ARK Genomic Revolution ETF
ARKG is an actively managed ETF that invests in the genomic revolution. It focuses on companies leading in gene editing, CRISPR technology, therapeutics, and molecular diagnostics, including firms like CRISPR Therapeutics and Tempus AI.
Read more on ARKG →About Paychex, Inc.
Paychex is a leading provider of payroll, human capital management, and insurance solutions servicing small and midsize clients primarily in the United States. The company, established in 1979, services over 730,000 clients and pays over 1 in 12 U.S. private-sector workers. Alongside its traditional payroll services, Paychex offers HCM solutions such as benefits administration and time and attendance software, as well as human resources outsourcing and insurance agency services.
Read more on PAYX →
